Cargando…

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force

Mostrar otras versiones (1)

OBJECTIVES: Deliberative processes for health technology assessment (HTA) are intended to facilitate participatory decision making, using discussion and open dialogue between stake-holders. Increasing attention is being given to deliberative processes, but guidance is lacking for those who wish to d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oortwijn, Wija, Husereau, Don, Abelson, Julia, Barasa, Edwine, Bayani, Diana (Dana), Santos, Vania Canuto, Culyer, Anthony, Facey, Karen, Grainger, David, Kieslich, Katharina, Ollendorf, Daniel, Pichon-Riviere, Andrés, Sandman, Lars, Strammiello, Valentina, Teerawattananon, Yot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613549/ https://www.ncbi.nlm.nih.gov/pubmed/35656641 http://dx.doi.org/10.1017/S0266462322000198

Ejemplares similares

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
por: Oortwijn, Wija, et al.
Publicado: (2022)

Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe
por: Oortwijn, Wija, et al.
Publicado: (2019)

Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide
por: Oortwijn, Wija, et al.
Publicado: (2021)

Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design − Part I: Conceptual Framework
por: Baltussen, Rob, et al.
Publicado: (2021)

The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan
por: Oortwijn, Wija, et al.
Publicado: (2022)

Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

Use of Evidence-Informed Deliberative Processes – Learning by Doing: Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Culyer, Anthony J.
Publicado: (2019)

ICER, ISPOR AND QALYs: Tales of Imaginary Worlds
por: Langley, Paul C
Publicado: (2019)

Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
por: Culyer, Anthony, et al.
Publicado: (2018)

All Male Panels and Other Diversity Considerations for ISPOR
por: Devlin, Nancy J.
Publicado: (2019)

Charging for the use of survey instruments on population health: the case of quality-adjusted life years
por: Teerawattananon, Yot, et al.
Publicado: (2020)

A Data-Driven Analysis of the Economic Cost of Non-Pharmaceutical Interventions: A Cross-Country Comparison of Kenya, Singapore, and Thailand
por: Briones, Jamaica, et al.
Publicado: (2022)

Reinforcing Science and Policy, With Suggestions for Future Research: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Culyer, Anthony J.
Publicado: (2022)

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice: Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2018)

Ethics in HTA: Examining the "Need for Expansion"
por: Abrishami, Payam, et al.
Publicado: (2017)

All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe
por: Bouvy, Jacoline C., et al.
Publicado: (2019)

Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group – Commentary
por: Wale, Janet L., et al.
Publicado: (2017)

Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making
por: Teerawattananon, Yot, et al.
Publicado: (2021)

Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy
por: Bentley, Colene, et al.
Publicado: (2019)

To include or not include: renal dialysis policy in the era of universal health coverage
por: Teerawattananon, Yot, et al.
Publicado: (2020)

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
por: Gad, Mohamed, et al.
Publicado: (2020)

Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report [5]()
por: Phelps, Charles E., et al.
Publicado: (2018)

Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5
por: Pitman, Richard, et al.
Publicado: (2012)

Emotion and Deliberative Reasoning in Moral Judgment
por: Cummins, Denise Dellarosa, et al.
Publicado: (2012)

The Place and Importance of Patients in Deliberative Processes
por: Cellier, Marjo S.
Publicado: (2021)

Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations
por: Butani, Dimple, et al.
Publicado: (2023)

Utilizing deliberative engagement for identifying implementation strategy priorities: lessons learned from an online deliberative forum with dental professionals
por: Gruß, Inga, et al.
Publicado: (2023)

Prioritization of COVID-19 vaccination. The added value of the “VALIDATE” approach
por: Refolo, Pietro, et al.
Publicado: (2022)

El mundo novelesco de Miguel Delibes /
por: Alvar, Manuel, 1923-2001
Publicado: (1987)

Contingency Management and Deliberative Decision-Making Processes
por: Regier, Paul S., et al.
Publicado: (2015)

Age-dependent changes in intuitive and deliberative cooperation
por: Nava, Francesco, et al.
Publicado: (2023)

Priority measures for publicly reporting primary care performance: Results of public engagement through deliberative dialogues in 3 Canadian provinces
por: Slater, Morgan, et al.
Publicado: (2020)

How to Account for Asymmetries in Deliberative Dialogues: Comment on "Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study"
por: Jiménez-Pernett, Jaime
Publicado: (2023)

The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand
por: Teerawattananon, Yot, et al.
Publicado: (2008)

Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study
por: Teerawattananon, Yot, et al.
Publicado: (2005)

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand
por: Pattanaphesaj, Juntana, et al.
Publicado: (2010)

Developing the protocol for the evaluation of the health foundation's 'engaging with quality initiative' – an emergent approach
por: Soper, Bryony, et al.
Publicado: (2008)

Using deliberative techniques to engage the community in policy development
por: Gregory, Judy, et al.
Publicado: (2008)

Including the public in pandemic planning: a deliberative approach
por: Braunack-Mayer, Annette J, et al.
Publicado: (2010)

Voting Intention and Choices: Are Voters Always Rational and Deliberative?
por: Lee, I-Ching, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o03cir4e1s9quna195ocl36sm9